PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

1.74
0.050   2.874%

Share volume: 4,189,235
Last Updated: 04-20-2026
Measuring And Control Equipment/Lab Analytical Instruments: 0.30%

PREVIOUS CLOSE
CHG
CHG%
$1.69
0.05
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
20%
Profitability 15%
Dept financing 16%
Liquidity 25%
Performance 25%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
6.75%
1 Month
25.18%
3 Months
-28.10%
6 Months
-8.42%
1 Year
52.63%
2 Year
11.54%
Key data
Stock price
$1.74
P/E Ratio 
0.00
DAY RANGE
$1.64 - $1.75
EPS 
-$1.82
52 WEEK RANGE
$0.85 - $2.73
52 WEEK CHANGE
$48.72
MARKET CAP 
564.567 M
YIELD 
N/A
SHARES OUTSTANDING 
301.998 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-06-2025
BETA 
1.19
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,587,539
AVERAGE 30 VOLUME 
$5,873,041
Company detail
CEO: Christian O. Henry
Region: US
Website: pacb.com
Employees: 730
IPO year: 2010
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. PacBio's Systems conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow.

Recent news